Course: How the US Failed to Prioritize SARS-CoV-2 Variant Surveillance
CME Credits: 1.00
Released: 2021-03-24
The day after Christmas last year, as COVID-19 cases burgeoned at Cedars-Sinai Medical Center in Los Angeles, a colleague asked Eric Vail, MD, whether a virus variant first detected in the UK was fueling the surge. Vail, the hospital’s director of molecular pathology, didn’t know. So the colleague, whom Vail describes as a high-level person at the hospital, asked him to look into it.
Less than a week later, Vail was close to finding an answer. “The sequencer was loaded on New Year’s Eve at 11 pm,” he recalled in a recent interview.
Educational Objective
To identify the key insights or developments described in this article
View Full Course